학술논문

Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease.
Document Type
Article
Source
Acta Pharmaceutica Sinica B; Feb2022, Vol. 12 Issue 2, p511-531, 21p
Subject
ALZHEIMER'S disease
DISEASE risk factors
BIOENERGETICS
DRUG development
MITOCHONDRIA
Language
ISSN
22113835
Abstract
Copyright of Acta Pharmaceutica Sinica B is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)